Trupanion (NASDAQ:TRUP) has earned a consensus recommendation of “Buy” from the eleven research firms that are presently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and seven have issued a buy rating on the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $35.33.
TRUP has been the subject of a number of research reports. Stifel Nicolaus reiterated a “buy” rating and issued a $34.00 price objective (up from $33.00) on shares of Trupanion in a research report on Wednesday, February 14th. BidaskClub lowered Trupanion from a “buy” rating to a “hold” rating in a research report on Sunday, December 24th. Lake Street Capital boosted their target price on Trupanion from $32.00 to $41.00 and gave the stock a “buy” rating in a research report on Wednesday, February 14th. ValuEngine lowered Trupanion from a “buy” rating to a “hold” rating in a research report on Wednesday, March 7th. Finally, Cowen restated an “outperform” rating and set a $38.00 target price (up from $32.00) on shares of Trupanion in a research report on Wednesday, February 14th.
In other news, Director Murray B. Low sold 3,000 shares of Trupanion stock in a transaction dated Thursday, February 22nd. The stock was sold at an average price of $28.42, for a total transaction of $85,260.00. Following the transaction, the director now owns 194,281 shares in the company, valued at approximately $5,521,466.02. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Darryl Rawlings sold 3,500 shares of Trupanion stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $34.36, for a total value of $120,260.00. Following the transaction, the insider now owns 1,382,976 shares in the company, valued at approximately $47,519,055.36. The disclosure for this sale can be found here. Insiders have sold a total of 21,500 shares of company stock valued at $642,465 over the last 90 days. Corporate insiders own 31.24% of the company’s stock.
Several large investors have recently added to or reduced their stakes in the company. Cambridge Investment Research Advisors Inc. bought a new position in shares of Trupanion during the 4th quarter valued at about $494,000. MetLife Investment Advisors LLC bought a new position in shares of Trupanion during the 4th quarter valued at about $324,000. PEAK6 Investments L.P. bought a new position in shares of Trupanion during the 4th quarter valued at about $289,000. Millennium Management LLC bought a new position in shares of Trupanion during the 4th quarter valued at about $6,851,000. Finally, Nine Ten Capital Management LLC lifted its holdings in shares of Trupanion by 0.7% during the 4th quarter. Nine Ten Capital Management LLC now owns 1,384,867 shares of the financial services provider’s stock valued at $40,535,000 after purchasing an additional 9,900 shares in the last quarter. Institutional investors and hedge funds own 74.81% of the company’s stock.
TRUP stock traded down $0.05 during midday trading on Wednesday, reaching $28.05. The stock had a trading volume of 120,792 shares, compared to its average volume of 364,274. The company has a quick ratio of 1.89, a current ratio of 1.89 and a debt-to-equity ratio of 0.19. The firm has a market cap of $825.52, a price-to-earnings ratio of -403.57 and a beta of 0.57. Trupanion has a twelve month low of $14.68 and a twelve month high of $37.13.
Trupanion (NASDAQ:TRUP) last announced its quarterly earnings data on Tuesday, February 13th. The financial services provider reported ($0.05) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.02) by ($0.03). The firm had revenue of $66.55 million during the quarter, compared to analyst estimates of $65.60 million. Trupanion had a negative return on equity of 6.66% and a negative net margin of 0.62%. sell-side analysts predict that Trupanion will post -0.05 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: This report was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this report on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.dispatchtribunal.com/2018/04/18/trupanion-trup-given-average-recommendation-of-buy-by-analysts.html.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.